Business Description
Lipocine Inc
NAICS : 325412
SIC : 2834
ISIN : US53630X1046
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.89 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.16 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 21 | |||||
3-Year EPS without NRI Growth Rate | 18.5 | |||||
3-Year FCF Growth Rate | 21.6 | |||||
3-Year Book Growth Rate | 1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -8.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.69 | |||||
Quick Ratio | 8.69 | |||||
Cash Ratio | 8.37 | |||||
Days Payable | 59.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.9 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 289.2 | |||||
Operating Margin % | 628.94 | |||||
Net Margin % | 573.55 | |||||
FCF Margin % | 411.96 | |||||
ROE % | -58.82 | |||||
ROA % | -54.58 | |||||
ROIC % | -853.18 | |||||
ROC (Joel Greenblatt) % | -13251.22 | |||||
ROCE % | -58.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 1.16 | |||||
EV-to-EBIT | 0.99 | |||||
EV-to-EBITDA | 0.99 | |||||
EV-to-Revenue | 5.68 | |||||
EV-to-FCF | 1.41 | |||||
Price-to-Net-Current-Asset-Value | 1.17 | |||||
Price-to-Net-Cash | 1.22 | |||||
Earnings Yield (Greenblatt) % | 100.58 | |||||
FCF Yield % | -48.77 |